Your browser doesn't support javascript.
loading
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy.
Meeuwsen, Miranda H; Wouters, Anne K; Jahn, Lorenz; Hagedoorn, Renate S; Kester, Michel G D; Remst, Dennis F G; Morton, Laura T; van der Steen, Dirk M; Kweekel, Christiaan; de Ru, Arnoud H; Griffioen, Marieke; van Veelen, Peter A; Falkenburg, J H Frederik; Heemskerk, Mirjam H M.
Afiliación
  • Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands. Electronic address: m.h.meeuwsen@lumc.nl.
  • Wouters AK; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Jahn L; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Kester MGD; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Remst DFG; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Morton LT; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • van der Steen DM; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Kweekel C; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.
  • Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands. Electronic address: m.h.m.heemskerk@lumc.nl.
Mol Ther ; 30(2): 564-578, 2022 02 02.
Article en En | MEDLINE | ID: mdl-34371177
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Neoplasias Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Neoplasias Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos